Oura has announced the acquisition of Counsel Health, an AI-native primary care startup, for $625 million, according to TechCrunch. This move marks a significant expansion for Oura beyond its core health tracking products into the AI-driven healthcare sector.
The acquisition comes just weeks after Oura postponed its planned IPO, which was valued up to $2.2 billion, indefinitely due to market uncertainties, TechCrunch reported. This strategic shift suggests Oura is focusing on strengthening its healthcare offerings amid volatile market conditions.
For Japanese investors, this deal highlights the growing intersection of AI and healthcare technology, a trend also gaining momentum within Japan’s own tech and medical sectors.
